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Abstract

Introduction and objectives. This study aims to investigate whether the cerebral
modifications of posttraumatic reactive astrocitose can be considered an objective criterion for
determining the age of traumatic cranio-cerebral lesions.
Materials and methods. The present study consists of a series of 23 medico-legal cases that
underwent autopsy in Teleorman County (Romania) Department of Forensic Medicine during
2007–2016, with full immune-histochemical microscopic examination using GFAP staining. The
study consists of two groups, a series of 13 cases with cranio-cerebral trauma with different
posttraumatic survival periods and 9 cases as a control group.
Results and discussions. We discovered GFAP+ reactive astrocytes even when death
occurred immediately after the trauma event and up to 4 months after the traumatic incident. We
also discovered an intense positive correlation between the density of the GFAP+ cell from the
perilesional area and the posttraumatic survival period. The highest cerebral density of the
GFAP+ astrocytes occurred with acute death prior (1 to 24 hours) and the lowest in the chronic
period (over 2 weeks).
Conclusions. The gradual and differentiated appearance of the reactive astrocytes in close
relation with the cerebral posttraumatic interval, with specific lesional and perilesional
distribution as well as in surrounding area, clearly demonstrates that the state of the reactive
astrocitose may constitute an objective index for evaluation of the elapsed time after the
posttraumatic event.
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The gradual and differentiated development of the reactive astrocytes in close relationship
with the time from the main trauma event, with specific lesional, perilesional, and far area
distribution demonstrates that studying the reactive astrocitose process can constitute as
an objective index for evaluating the posttraumatic elapsed time.
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The reaction of the glial cells plays a significant role in the development of cranio-cerebral
lesions
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Introduction
Astrocytes are the most known neuroglial
components, being five times denser than neurons and
being a common part of the central nervous system of
all vertebrates. Reactive astrocitose is a specific process
in which the astrocytes respond to all cerebral lesions,
being a result of structural lesions upon the central
nervous system. Reactive astrocitose consists of a broad
range of astrocyte transformations, starting with
reversible gene expressions or light cellular hypertrophy
with integrity of the tissue and cell internal architecture
and ending up with definitive glial scar construction
through rearrangement of the cerebral histological
elements. The immuno-histochemical study of the glial
fibrillar acid protein (GFAP) expression is used as a
typical marker for identifying the reactive astrocytes,
other molecular markers used for this immunehistochemical determination being glutamin-systethase
and S100ß (1, 2). The utility of these markers is
nevertheless limited because, in contrast to the GFAP,
they are not specific to astrocytes cells. GFAP is an
extremely stable fibrillar intermediate protein, being
also an essential structural component of the astrocyte
cell internal cytoskeletal structure that, under normal
physiological conditions, cannot be found dispersed in
the cytoplasmic fluid. Also, GFAP cannot be detected
through immune-histochemical techniques in nonreactive astrocytes. Experimental studies have shown
that GFAP is not essential for normal physiological
functions of the astrocyte cell, but it is important in
reactive astrocitose processes and for glial scar
development (3, 4).
This study investigates whether the use of immunehistochemical techniques with GFAP staining for
cerebral modifications of reactive astrocitose can
constitute an objective criterion for determining the age
of traumatic cranio-cerebral lesions.

Material and method
This study analyzed the autopsy cases performed in
Teleorman County, Romania, Department of Forensic
Medicine from 2007–2016. It includes a retrospective
observation between 2007 and 2014 and a prospective
study between 2015 and 2016. Of the entire lot of
autopsies performed, we selected 22 cases for
microscopic evaluation, with 2 sub-batches. The first lot
included 13 cases with deaths from posttraumatic
cranio-cerebral lesions, with variable survival times,
ranging from instant death up to 4 months survival time.
All selected cases had a violent pattern of trauma onset
(4 physical aggressions, 6 road accidents, 1 free fall, 1

fall within the same height, and 1 case of undetermined
conditions). We did not include those cases with
neurosurgical postoperative lesions, as various
postoperative conditions could have interfered with the
initial macro- and microscopical cerebral lesions. Based
on posttraumatic survival times, these cases were further
divided into 4 categories:
- Death within the supra-acute period, of seconds and
minutes and up to hours from the initial trauma event: 3
cases;
- Death within the acute period, ranging form1 hour and
up to 24 hours after the trauma event: 3 cases;
- Death within the sub-acute period, ranging from 1 day
and up to 14 days: 3 cases;
- Death during the chronic period, after 2 weeks post
trauma: 4 cases.
A second lot consisted of 9 cases selected for
comparison as a control group, with no cranio-cerebral
events and no cerebral lesions detected during autopsy.
We did not include in this lot cases with known cerebral
vascular diseases. These cases had both violent (5 cases)
and non-violent (4 cases) mechanisms of death onset
from the following: mechanical asphyxia through
strangulation, phosphorous-organic acute intoxication,
underwater mechanical asphyxia, hypothermia,
myocardial fibrosis, acute myocardial infarction,
pulmonary thromboembolism, toxic-septic shock, and
electrocution.
• Techniques employed by the study
For each case, we harvested during autopsy cerebral
tissue samples of approx. 3 by 2 cm that were later
immersed in fixation dye based on a 10% buffered
formalin solution and hermetically sealed in recipients
should this be receptacles? with a 5 times larger volume
of formalin solution than the tissue mass, for a period of
2 weeks. The tissue samples were later embedded in
paraffin blocks, each of them with 3 serial sections of
1.5-2 µm thickness. These sections were stripped of
paraffin and rehydrated and dyed using a standard
Hematoxilin-Eozine (HE) staining. The final step
consisted of a manual technique for immunohistochemical staining.
For the GFAP-revealing immune-histochemical
staining, we employed the following steps: as a first
measure we blocked the intrinsic peroxidase activity by
treating the sections with Peroxidazed-1 for 5 minutes at
room temperature. Then, the revealing of the GFAP
antigen was achieved by the Heat Induced Epitope
Retrieval method (HIER) with boiling at 950C for 45
minutes with the aid of a Decloaking Chamber.
Blocking of the non-specific staining was achieved by
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treating the sections with Background Sniper solution
(Biocare Medical©) for 10 minutes at room temperature.
Applying the primary GFAP(M) antibody was achieved
by delivering the GA-5 clone mice-produced
monoclonal anti-GFAP(M) antibody on the sections
(Biocare Medical©) with the factory recommended
dilution of 1:100 for 60 minutes at room temperature.
Detection of the probe/polymer was achieved by
applying first the probe for 10 minutes then the universal
polymer for 20 minutes. The antibodies were identified
by means of the MACH 4 Universal HRP-Polymer
detection system (Biocare Medical©) which can detect
both anti-rabbit and anti-mice antibodies. After each of
these steps, the blades were washed with buffer solution
with a pH of 7.6 (TBS Plus, by Biocare Medical©).
Applying the DAB chromogen was achieved by fixing
the blades Betazoid DAB solution (Biocare Medical©)
for 2 minutes at room temperature. Later, we washed
them for 1 minute with deionized water and after this
step the overcoloring was done with CUT Hematoxylin,
followed by dehydration, clarifying, and mounting the
sections on the final lamellas.
• Microscopical examination
Brain fragments were examined with light
microscopy and different magnifying lenses provided by
the Leica ICC 50W transmitted light microscope with an
attached photography kit. For the cranio-cerebral trauma
cases, we performed a regional quantitative analysis of
the GFAP-positive cells determining the final mean
number of cells at the level of lesion, adjacent area, and
far surroundings. Two independent observers each
analyzed 5 microscopic fields with a 20x lens for 3
blades of the same case by employing a standard
viewport grill and therefore obtaining the mean number
of GFAP-positive cells distributed at the level of the
lesion, the adjacent zone, and the far surrounding area.
We report them as an arithmetic mean between the
determinations of each case. The final number of GFAPpositive cells for the corresponding areas was
determined as a mean computation between the figures
reported by the two independent observers. The GFAPpositive cell density at the level of each area was
determined by reporting the final mean number of cells
per square mm of brain tissue.
• Statistical analysis
Data were parsed with the SPSS analysis software
(SPSS for Microsoft Windows, ver. 17.0). Statistical
analysis focused on brain density of the GFAP-positive
cells, as a continuous variable, described both globally
as well as on layers, on subgroups of interest, by the
central trend (mean, median) and dispersion (standard

deviation). During the analytical stage, comparison of
the subgroups and validation of the hypothesis were
achieved using the t-test for independent samples and
with the non-parametric Mann-Witney U test when the
assumption of a normal distribution was not met.
ANOVA as well as the non-parametric Kruskal-Wallis
test were used for establishing differences between
various parameters within the studied groups.
Differences between the 2 lots of cases were considered
significant using p of 0.05. Data were then transformed
into standard graphical representations.

Results
In the supra-acute posttraumatic period, we detected
GFAP-positive cells with light to moderate hypertrophy.
During the acute, sub-acute, and chronic intervals, the
GFPA-positive
astrocytes
developed
severe
hypertrophy. Development of the glial scars was noted
starting with 1 to 2 months after the trauma event.
During the supra-acute post-traumatic period for the
GFAP-positive astrocytes with light hypertrophy, GFAP
staining was observed mostly in the body of the
astrocytes, and lighter at the outer limits of the cells. As
for the GFAP-positive astrocytes with moderate
hypertrophy,
GFAP
staining
was
immunohistochemically present at both the body of the cell (that
looks inflated) as well as in the outer limits of the cells
that appear thickened. (Figure 1, Figure 2, A-B).

Figure 1. Immediate posttraumatic death. A, B:
(lesional/perilesional), low immunopositivity
reaction of the GFAP-positive staining with growth
of the GFAP+ cells at the lesional and perilesional
levels; astrocytes slightly hypertrophic in aspect,
mostly in the body of the cells, extensions of the
astrocytes with a filament-like aspect. At 25
minutes posttraumatic: C (lesional-perilesional),
D (perilesional) – positive reduced immunoreaction
of GFAP+ with a light hypertrophy aspect of the
astrocyte, ballooning of the cell body with thin
cellular extensions and a perineuronal tree-like
aspect in the areas of ischemic perilesional zones.
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astrocyte cells at the perilesional level. GFAP-positive
astrocytes
presented
severe
hypertrophic
modifications, cell body with increased volume,
thickened cell extensions, rare areas of overlapping. At
1 day posttraumatic: C, D (perilesional) an increased
immunopositivity of the GFAP reaction, severe
astrocyte hypertrophy, fragmentation of the astrocyte
cells, increased cell volume that appears separated
from the adjacent cell extensions. At 6 days
posttraumatic:
E
(lesional-perilesional),
F
(perilesional) an increased immunopositivity of the
GFAP reaction, low GFAP-positive cell density,
especially at the lesional level. Astrocytes with severe
hypertrophic modifications, increased volume of the
body, multiple thickened extensions, lots of
overlapping astrocyte areas.
During the acute and sub-acute posttraumatic
periods at the level of astrocytes with severe
Figure 2. At 45 minutes posttraumatic: A (lesionalperilesional), B (perilesional) moderate immunopositivity of the GFAP reaction with multiple astrocyte
cells moderately hypertrophied, both a lesional and
perilesional levels, with an 8-times growth in volume
of the cell body and cell extension thickening, without
any astrocyte overlapping. At 1 hour posttraumatic:
C, D (perilesional) moderate GFAP positive reaction,
moderate hypertrophy of the astrocyte cells, cell body
with an increased volume and with numerous
thickened cell extensions, rare overlapping zones. At 3
hours posttraumatic: E (lesional), F (perilesional) a
high positive reactivity of the GFAP reaction,
numerous astrocytes with moderate hypertrophy, cell
body with a considerable volume growth and thickened
cell extensions with lots of overlapping zones (F).

hypertrophy, GFAP staining revealed a volumetric
growth of the body and outer limits of the astrocytes as
well as fragmentation of the astrocyte pseudopods
(ranging from light fragmentation during the acute
period to severe fragmentation in the sub-acute timing)
(Figure 2: C and D; Figure 3; Figure 4: A and B).

Figure 4. At 8 days posttraumatic: A, B (lesional)
an increased immunopositivity of the GFAP reaction,
a reduced number of GFAP-positive cells with
alteration of the cellular morphology, cell body with
a very large volume that appears separated from the
astrocyte extensions. At 2 weeks posttraumatic: C,
D (lesional) an increased immunopositivity of the
GFAP reaction, with severe hypertrophy and
morphological alterations of the cell body, extended
Fig. 3. At 6 hours posttraumatic: A (lesional), B
(lesional-perilesional) an increased immuno-positivity
of the GFAP reaction, numerous GFAP-positive

lesions of cell fragmentation, dispersed aspect of the
body and cell extensions.
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included the cranio-cerebral trauma cases with variable
posttraumatic survival times) compared to the control
group (that showed a history of cranio-cerebral trauma
with different causes for death) (Chart 1).

Figure 5. At 1 month posttraumatic: A (lesionalperilesional),
B
(lesional)
an
increased
immunopositivity of the GFAP reaction, numerous
GFAP-positive astrocyte cells at the perilesional level,
cell body with increased volume, thickened cell
extensions, severe reactive astrocytosis with glial scar
formation. At 2 months posttraumatic: C, D
(lesional) laminar necrosis with gliosis, an increased
immunopositivity of the GFAP reaction, severe
hypertrophy, many overlapping areas of the cell
extensions and forming of extended glial scars. At 4
months posttraumatic: E, F (lesional-perilesional)
an increased immunopositivity of the GFAP reaction,
a reduced number of GFAP-positive cells with
alteration of the cellular morphology, numerous
astrocyte bodies separated by astrocyte extensions and
many overlapping areas
During the chronic posttraumatic survival period,
we noticed severe astrocyte hypertrophy, the body of the
cells being overinflated with numerous thickened
extensions and overlapping of the pseudopods, thus
creating glial scars (Figure 4- C and D; Figure 5). The
GFAP-positive astrocyte response observed in most of
the control cases was diffuse in the brain tissue, with
light hypertrophy of the cell`s body, without any
hypertrophic modifications of the astrocyte extension
and with no fragmentation or overlapping of the
astrocyte pseudopods (Figure 6). In only one case from
the control group did we notice severe reactive
astrocitose, a high number of GFAP-positive cells being
present in the perivascular area with a diffuse
disposition indicating a general glial reaction, a
characteristic for a toxic encephalitic process?
Statistical analysis on the density of the GFAPpositive brain cells revealed significant effects (p < 0.05)
between the two groups. The density of the brain GFAPpositive cells was higher in both the amplitude and in the
central trend for the cases in the study group (that

Fig. 6. Analysis of the control group. Reduced
intensity of the immunohistochemical GFAP staining,
rare astrocytes with light hypertrophy and diffuse
dispersion in the brain tissue, a slightly larger cell body
with lots of thin cell extensions in the case of organophosphorus
intoxication
(A),
pulmonary
thromboembolism (B) and strangling (C). Moderate
GFAP staining, moderate cell count and slight
hypertrophy with homogenous dispersion, ballooning
of the cell body with filament-like astrocyte
pseudopods in myocardial-fibrosis (D) and
hypothermia (E). Moderate GFAP reaction, increased
expression of the GFAP-positive cells with light
hypertrophy in diffuse focal arrangement near the blood
vessels in electrocution (F). A balloon-like cell body
with thin cell extensions with no overlapping areas of
the astrocytes.

Chart 1. The variation of GFAP-positive cerebral
cell density between the 2 groups.
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In the immediate posttraumatic death and up to 25
minutes of survival time after the trauma event, we
noticed the same density of GFAP-positive cells (25
cells per square mm of brain tissue), with a doubling at
the 45 minutes and 1-hour posttraumatic marks. At the
3-hour posttraumatic survival mark, we recorded the
highest density of GFAP-positive cells, at 78 cells per
square mm of brain tissue, followed by a steep decline
in density at 6 hours posttrauma with a 38 cell per
square mm value, followed by a slow descent of up to 1
month after the traumatic event, with a count of 15 cells
per square mm of brain tissue.
At the two-month posttraumatic mark, we
registered a slight elevation in GFAP-positive cell
density at both lesional and peri-lesional level, with 24
cells per square mm. At 4 months of posttraumatic
survival time we noticed the lowest GFAP-positive
brain cells density (Chart 2).

Chart 3. The variation in density of GFAPpositive cerebral cells lesional/perilesional in
regards with the posttraumatic survival time.
Legend: GFAP+L: GFAP+ lesional cells;
GFAP+P: GFAP+ perilesional cells; GFAP+D:
GFAP+ cells at the outer limits of the lesional
area.
Regarding the lesional area, the density of GFAPpositive cells at the site of the lesion and adjacent area
was significant larger (p = 0.0221 and 0.0277
respectively) compared with those situated farther
away.
The maximum values for GFAP-positive cells
occurred at the perilesional site (median of 17.08 cells
per square mm of brain tissue) followed by GFAPpositive cells at the lesional site (median of 11.92 cells
per square mm of brain tissue); the lowest value was

Chart 2. The variation of GFAP-positive cerebral
cell density in connection with the survival
posttraumatic time between the 2 groups.
At 3-hours posttraumatic index, the study revealed
the highest density of GFAP-positive cells at both
lesional and peri-lesional levels, of about 35 cells per
square mm and 40 cells per square mm of brain tissue.
At 4 months, no GFAP-positive cells were seen at the
lesional level, this being their lowest density. Between
1 and 4 months posttrauma, we also noticed a reduced
density of GFAP-positive cells at the level of the lesion,
with values ranging from 2 to 5 cells per square mm of
brain tissue.
The GFAP-positive cells situated far from the
cerebral lesions were not detected during the first hour
following the trauma event. The highest density of
GFAP-positive cells situated away from the lesional
site was recorded at 4 months post trauma, with 9 cells
per square mm of brain tissue (Chart 3).

recorded for GFAP-positive cells being the farthest
away from the lesion (median of 3 cells per square mm
of brain tissue) (Table 1).
If the analysis examines the lesional area and the
period of death, the density of GFAP-positive cells
differs significantly in comparison to the lesional site
situated far away (p = 0.005).
The maximum density of GFAP-positive cells from
the level of the lesion was encountered during the subacute death. The maximum density of the GFAPpositive cells at the perilesional area occurred during
the acute death, and the lowest during the sub-acute
death.
In the case of the supra-acute, acute, and sub-acute
death, perilesional GFAP-positive cells were closer to
the outer limits, with each statistically significant (p =
0.0462, 0.0023 and 0.0151 respectively) (Table 1).
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Number of GFAP+/mm2 of brain
tissue/lesional area

Period of
Death Onset

GFAP+

GFAP+

GFAP+

Lesional Perilesional outer area
1.
N
Supra
acute
Median
death

3

3

3

16,00

19,00

2,00

3

3

3

20,33

33,33

2,00

3

3

3

6.33

15,00

3,00

N

4

4

4

Median

6,75

5,00

6,00

2.
N
Acute
death Median
3.
N
Sub
acute
Median
death
4.
Chronic
death

p
Total

(p=0.176) (p=0.005) (p=0.005)
N

13

13

13

Median

11.92

17,08

3,00

Table 1. Comparison between the cerebral
density of the GFAP-positive cells in regards with
the lesional area and the elapsed posttraumatic
time.
Regarding the lesional area and the posttraumatic
survival time, results showed a strong positive
correspondence between the cerebral density of GFAPpositive cells from the lesional, perilesional, and outer
limits as well as negative correspondence between the
cerebral densities of the GFAP-positive cells from the
perilesional and the outer limit areas.
In the control group with cranio-cerebral lesions,
the GFAP-positive cells placed at the outer limits of the
lesional points, density was directly related with
survival posttraumatic time; the greater the density, the
longer was the time.

Discussions
Experimental studies conducted on mice by
Kalayci and Woiciechowskyha have identified specific
modifications of reactive astrocytosis beginning with
the 24-hour posttraumatic marker, consisting in a

hypertrophic astrocyte reaction with a maximum at 3-4
days post trauma. These researchers also showed that
diffuse cranio-cerebral trauma can lead to light
astrogliosis with moderate diffusion, the GFAPpositive astrocytes presenting different grades of
hypertrophy, without registering losses in the fields of
the astrocytes and without the constitution of glial scars
(5, 6).
The studies of Zhonghua et al., based on the
experimental induction of lesions at the cerebral trunk
in mice, revealed typical reactive astrocytosis
beginning at 15 minutes and up to 15 days post-trauma.
The first reactive astrocytosis modifications recorded at
15 minutes consisted in bloating of the astrocyte cells
with reduced immunopositivity of GFAP staining.
Between 1 and 3 hours post trauma, the astrocytes
displayed significant hyperplasic modifications, and
between the 1-hour to 6-hour markers, the study showed
astrocyte hyperplasic with moderate hypertrophy, with
a relatively low intensity of the staining. Between 24hours and 96-hours, an elevated number of moderate
hypertrophic astrocytes and a high intensity of the
staining were evident. Between 10 to 15 days after the
trauma, their study revealed both hypertrophy and
hyperplasic processes, with the most intense coloration
of the GFAP staining (7).
Haussman et al. have investigated the
immunohistochemical reactions of the reactive
astrocytosis processes that take place in the brain tissue
in the first 30 weeks after a traumatic event. Between
the 1st day and the 4th week, numerous GFAP-positive
hypertrophic astrocytes were found in the surrounding
areas of some cortical brain concussions (8).
Summarizing the results of the experimental data
regarding the reactive astrocytosis process with the aid
of the GFAP staining, we can conclude that the earliest
presence of the GFAP-positive cells is 15 minutes after
a trauma event and this lasts up to a month posttrauma.
In this study we identified GFAP-positive astrocyte
cells immediately after death and up to 4 months after
the traumatic event, with direct correlations between the
brain density of the GFAP-positive hypertrophic
astrocytes and the posttraumatic time lapsed, in the first
3 hours a progressive growth of the GFAP-positive
brain cells with a later slight downturn in their numbers
up to the 4-month marker.
The majority of the published experimental data
regarding the reactive astrocytosis processes has
revealed an increased expression of the GFAP-positive
cells at the lesional and peri-lesional level, but none of
those studies investigated the reactive astrocitose
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phenomenon in the outer limits areas, away from the
initial brain injuries (9).
This study revealed that the GFAP-positive cells
are mostly located at the lesion site and the perilesional
areas, with a reduced density in the outer limits of the
brain injury. We also noticed a strong positive
correlation between the GFAP-positive cell density
from the perilesional areas and the outer limits in close
relationship with the posttraumatic survival time of the
case.

Conclusions
The study of the reactive astrocitose processes in
the cranio-cerebral trauma, investigated through GFAP
immunohistochemical staining, has identified a broad
spectrum of astrocyte cell transformations in close
relationship with the posttraumatic elapsed time.
During the supra-acute period, the study revealed light
hypertrophic and moderate astrocitose processes with a
reversible potential, along with a growth in volume of
the cell body as well as the cell extensions, variable
fragmentation of the astrocyte pseudopods, without
altering of the tissue architecture. During the acute, subacute, and chronic post-traumatic periods, the study
revealed irreversible modifications consisting of severe
hypertrophy with numerous areas of astrocyte
overlapping and glial scar developing along with
rearranging of the brain histological elements beginning
with 1 month and up to 2 months posttrauma. The
highest cerebral density of the GFAP-positive
astrocytes was noticed in the acute period of death (1 to
2 hours) and the lowest in the chronic period (over 2
weeks).
The gradual and differentiated development of the
reactive astrocytes in close relationship with the time
from the main trauma event, with specific lesional,
perilesional, and far area distribution demonstrates that
studying the reactive astrocitose process can constitute
as an objective index for evaluating the posttraumatic
elapsed time.
The reaction of the glial cells plays a significant
role in the development of cranio-cerebral lesions,
during the early stage (when the clinical landscape is
dominated by the primary traumatic lesions) and also
during the late stage (when the clinical evolution is
influenced mostly by the secondary cerebral injuries).

`The role of forensic investigation in diagnosis,
prognosis and estimation of posttraumatic interval in
TBI `.
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